Joshua Kazam


Joshua Kazam is a co-founder and Partner of Two River, where he has served as partner since its inception in 2004. Prior to founding Two River, he served as Managing Director of a life science focused venture capital firm.

Mr. Kazam is a co-founder, officer and director of Allogene Therapeutics Inc. He is a co-founder and partner of Vida Ventures. Mr. Kazam was also a co-founder and director of Kite Pharma where he served on the board until its acquisition by Gilead (GILD) in 2017. He also serves on the Board of Directors of Capricor Therapeutics (CAPR). Mr. Kazam also serves as a director of several privately held companies including Second Science and Hubble Contacts.

Mr. Kazam is a Member of the Wharton School’s Undergraduate Executive Board and serves on the Board of Directors of the Desert Flower Foundation. Mr. Kazam received his B.S. in Economics from the Wharton School of the University of Pennsylvania.